Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine protease 41 (PRSS41) is a protein-coding gene in Homo sapiens, located on chromosome 16. It encodes a predicted serine-type endopeptidase, likely involved in proteolytic processes and thought to reside in the plasma membrane. PRSS41 is a member of the serine protease family; its expression and function in humans remains incompletely characterized, but mouse paralogs are known to be testis-specific and are implicated in spermatogenesis and germ cell survival during meiosis[1][2][3][4][5][6][7]. There are no validated drug interactions, biomarkers, or disease associations currently reported for PRSS41.
Not established for drugs, as no drug interaction reported. Putative mechanism: proteolytic cleavage of peptide substrates by serine active site
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine protease 41 (PRSS41).